A detailed history of High Point Advisor Group LLC transactions in Zoetis Inc. stock. As of the latest transaction made, High Point Advisor Group LLC holds 12,093 shares of ZTS stock, worth $1.99 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
12,093
Previous 13,467 10.2%
Holding current value
$1.99 Million
Previous $2.33 Million 1.2%
% of portfolio
0.14%
Previous 0.13%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$172.58 - $196.48 $237,124 - $269,963
-1,374 Reduced 10.2%
12,093 $2.36 Million
Q2 2024

Aug 08, 2024

BUY
$145.54 - $178.83 $590,164 - $725,155
4,055 Added 43.08%
13,467 $2.33 Million
Q1 2024

May 14, 2024

SELL
$165.67 - $199.94 $53,677 - $64,780
-324 Reduced 3.33%
9,412 $1.59 Million
Q4 2023

Mar 26, 2024

BUY
$151.44 - $200.09 $194,146 - $256,515
1,282 Added 15.16%
9,736 $1.92 Million
Q2 2022

Aug 15, 2022

SELL
$155.97 - $200.09 $241,753 - $310,139
-1,550 Reduced 15.49%
8,454 $1.51 Million
Q3 2021

Nov 15, 2021

BUY
$189.29 - $209.69 $85,180 - $94,360
450 Added 4.71%
10,004 $1.94 Million
Q2 2021

Jul 29, 2021

BUY
$155.9 - $187.99 $400,039 - $482,382
2,566 Added 36.72%
9,554 $1.78 Million
Q1 2021

Apr 12, 2021

BUY
$144.0 - $169.39 $90,000 - $105,868
625 Added 9.82%
6,988 $1.12 Million
Q4 2020

Feb 10, 2021

BUY
$157.07 - $174.35 $268,275 - $297,789
1,708 Added 36.69%
6,363 $1.02 Million
Q3 2020

Nov 06, 2020

SELL
$137.1 - $165.37 $5,621 - $6,780
-41 Reduced 0.87%
4,655 $796,000
Q2 2020

Aug 13, 2020

BUY
$111.92 - $142.53 $63,122 - $80,386
564 Added 13.65%
4,696 $644,000
Q1 2020

May 01, 2020

BUY
$92.66 - $144.94 $334,687 - $523,523
3,612 Added 694.62%
4,132 $520,000
Q1 2020

Apr 27, 2020

SELL
$92.66 - $144.94 $333,390 - $521,494
-3,598 Reduced 87.37%
520 $4.13 Million
Q4 2019

Feb 13, 2020

BUY
$116.25 - $133.25 $26,505 - $30,381
228 Added 5.86%
4,118 $583,000
Q3 2019

Nov 12, 2019

BUY
$112.57 - $128.43 $32,870 - $37,501
292 Added 8.12%
3,890 $458,000
Q2 2019

Aug 15, 2019

BUY
$97.98 - $114.28 $37,526 - $43,769
383 Added 11.91%
3,598 $417,000
Q1 2019

May 08, 2019

BUY
$81.56 - $100.67 $55,705 - $68,757
683 Added 26.97%
3,215 $325,000
Q4 2018

Feb 20, 2019

BUY
$79.28 - $95.27 $6,421 - $7,716
81 Added 3.3%
2,532 $240,000
Q3 2018

Oct 24, 2018

BUY
$83.5 - $93.23 $1,670 - $1,864
20 Added 0.82%
2,451 $227,000
Q2 2018

Aug 20, 2018

SELL
$79.9 - $89.2 $4,634 - $5,173
-58 Reduced 2.33%
2,431 $223,000
Q1 2018

Jun 11, 2018

BUY
$71.51 - $84.69 $177,988 - $210,793
2,489 New
2,489 $216,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $77.1B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track High Point Advisor Group LLC Portfolio

Follow High Point Advisor Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Point Advisor Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Point Advisor Group LLC with notifications on news.